Compare ARK Genomic Revolution ETF (ARKG) vs abrdn Physical Palladium Shares ETF (PALL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs abrdn Physical Palladium Shares ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while abrdn Physical Palladium Shares ETF trades at $22.87. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, abrdn Physical Palladium Shares ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | PALL | |
|---|---|---|
Sector | Sector/Thematic | Commodities - Metals/Agriculture |
52-Week High | $43.57 | $37.18 |
52-Week Low | $23.09 | $19.96 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
PALL (abrdn Physical Palladium Shares ETF) trades at $23.07, up 1.63% with bearish technical signals from moving averages but neutral oscillators. The ETF recently underwent a 5-for-1 stock split effective May 18, 2026. Financial ratios are unavailable, but palladium's 47% price decline from January 2026 highs has drawn attention as a potential catch-up trade amid broader precious metals strength.
The outlook hinges on palladium's supply-demand dynamics, with Seeking Alpha highlighting a buying opportunity at current levels due to industrial demand and supply risks. Key risks include Federal Reserve policy impacts and commodity volatility. Analyst sentiment is cautiously optimistic, viewing the price weakness as a potential entry point for exposure to palladium's recovery prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About abrdn Physical Palladium Shares ETF
PALL is a physically-backed ETF that tracks the spot price of palladium. It holds physical bullion in secure vaults, offering a liquid way to invest in this precious metal primarily used in automotive catalytic converters and electronics.
Read more on PALL →
